NANX
Nanophase Technologies Corporation [NANX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NANX Stock Summary
Top 10 Correlated Stocks
NANX
In the News
NANX Financial details
Company Rating
Buy
Market Cap
51.24M
Income
-4.21M
Revenue
37.3M
Book val./share
0.04
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
79
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-6.46
Forward P/E
-
PEG
-1.09
P/S
0.7
P/B
6.69
P/C
32.53
P/FCF
-9.62
Quick Ratio
0.25
Current Ratio
0.88
Debt / Equity
6.37
LT Debt / Equity
3.15
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-
EPS this Y
65.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.16%
Revenue last 5Y
24.42%
Revenue Q/Q
0.67%
EPS Q/Q
47.59%
-
-
-
-
SMA20
53.45%
SMA50
81.63%
SMA100
2.3%
Inst Own
1.03%
Inst Trans
0.96%
ROA
-13%
ROE
-84%
ROC
-0.24%
Gross Margin
22%
Oper. Margin
-9%
Profit Margin
-11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.32-1.49
52W High
-
52W Low
-
RSI
66.1
Rel Volume
0.98
Avg Volume
9.92K
Volume
9.75K
Perf Week
26.59%
Perf Month
15.16%
Perf Quarter
2.74%
Perf Half Y
-2.4%
-
-
-
-
Beta
1.49
-
-
Volatility
0.05%, 0.14%
Prev Close
2.74%
Price
0.976
Change
4.5%
NANX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.34 | 0.45 | 0.65 | 0.76 | 0.75 | |
| Net income per share | -0.09 | 0.01 | 0.05 | -0.05 | -0.09 | |
| Operating cash flow per share | -0.08 | -0.05 | 0.05 | -0.03 | -0.04 | |
| Free cash flow per share | -0.1 | -0.08 | 0.01 | -0.09 | -0.06 | |
| Cash per share | 0.03 | 0.03 | 0.01 | 0.04 | 0.03 | |
| Book value per share | 0.04 | 0.07 | 0.17 | 0.12 | 0.04 | |
| Tangible book value per share | 0.04 | 0.07 | 0.17 | 0.12 | 0.04 | |
| Share holders equity per share | 0.04 | 0.07 | 0.17 | 0.12 | 0.04 | |
| Interest debt per share | 0.14 | 0.21 | 0.35 | 0.38 | 0.26 | |
| Market cap | 10.25M | 32.43M | 198.09M | 55.5M | 29.73M | |
| Enterprise value | 14M | 39.05M | 212.19M | 71.42M | 49.27M | |
| P/E ratio | -3.19 | 65.75 | 85.38 | -21.16 | -6.77 | |
| Price to sales ratio | 0.82 | 1.89 | 6.72 | 1.49 | 0.8 | |
| POCF ratio | -3.69 | -15.74 | 85.35 | -33.64 | -14.82 | |
| PFCF ratio | -2.91 | -11.04 | 443.16 | -12.41 | -9.73 | |
| P/B Ratio | 6.78 | 11.87 | 26.54 | 9.83 | 15.63 | |
| PTB ratio | 6.78 | 11.87 | 26.54 | 9.83 | 15.63 | |
| EV to sales | 1.12 | 2.28 | 7.2 | 1.91 | 1.32 | |
| Enterprise value over EBITDA | -5.04 | 25.93 | 60.01 | -32.06 | -17.57 | |
| EV to operating cash flow | -5.04 | -18.95 | 91.42 | -43.29 | -24.56 | |
| EV to free cash flow | -3.98 | -13.29 | 474.69 | -15.97 | -16.12 | |
| Earnings yield | -0.31 | 0.02 | 0.01 | -0.05 | -0.15 | |
| Free cash flow yield | -0.34 | -0.09 | 0 | -0.08 | -0.1 | |
| Debt to equity | 3.28 | 2.77 | 1.98 | 3.2 | 6.37 | |
| Debt to assets | 0.53 | 0.56 | 0.52 | 0.54 | 0.37 | |
| Net debt to EBITDA | -1.35 | 4.39 | 3.99 | -7.14 | -6.97 | |
| Current ratio | 1.13 | 1.3 | 1.33 | 0.99 | 1.05 | |
| Interest coverage | -13.32 | 2.99 | 3.04 | -5.91 | -4.23 | |
| Income quality | 0.92 | -2.08 | 1 | 0.63 | 0.46 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.28 | 0.17 | 0.13 | 0.2 | 0 | |
| Research and developement to revenue | 0.15 | 0.09 | 0.08 | 0.08 | 0.1 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.27 | 0.43 | -0.81 | 1.71 | 0.52 | |
| Capex to revenue | -0.06 | -0.05 | -0.06 | -0.08 | -0.03 | |
| Capex to depreciation | -2.35 | -2.45 | -4.13 | -4.98 | -1.42 | |
| Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Graham number | 0.29 | 0.14 | 0.44 | 0.37 | 0.28 | |
| ROIC | -0.32 | 0.06 | 0.1 | -0.07 | -0.15 | |
| Return on tangible assets | -0.34 | 0.04 | 0.08 | -0.08 | -0.13 | |
| Graham Net | -0.13 | -0.14 | -0.32 | -0.36 | -0.44 | |
| Working capital | 575.82K | 2.05M | 2.87M | -210K | 713K | |
| Tangible asset value | 1.51M | 2.73M | 7.47M | 5.65M | 1.9M | |
| Net current asset value | -2.88M | -1.97M | -9.33M | -11.28M | -14.68M | |
| Invested capital | 3.28 | 2.77 | 1.98 | 3.2 | 6.37 | |
| Average receivables | 899.74K | 1.95M | 3.43M | 4.34M | 4.1M | |
| Average payables | 1.68M | 1.94M | 2.85M | 4.96M | 6.38M | |
| Average inventory | 2.4M | 3.45M | 5.22M | 7.47M | 9.44M | |
| Days sales outstanding | 28.32 | 62.51 | 48.75 | 46.3 | 33.93 | |
| Days payables outstanding | 64.49 | 69.71 | 62.62 | 80.2 | 79.11 | |
| Days of inventory on hand | 94.21 | 142.29 | 107.03 | 111.41 | 124.23 | |
| Receivables turnover | 12.89 | 5.84 | 7.49 | 7.88 | 10.76 | |
| Payables turnover | 5.66 | 5.24 | 5.83 | 4.55 | 4.61 | |
| Inventory turnover | 3.87 | 2.57 | 3.41 | 3.28 | 2.94 | |
| ROE | -2.13 | 0.18 | 0.31 | -0.46 | -2.31 | |
| Capex per share | -0.02 | -0.02 | -0.04 | -0.06 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.17 | 0.19 | 0.24 | 0.16 | 0.16 | |
| Net income per share | -0.04 | -0.02 | 0.01 | -0.03 | -0.04 | |
| Operating cash flow per share | 0.02 | -0.02 | -0.02 | 0.05 | -0.05 | |
| Free cash flow per share | -0.01 | -0.02 | -0.04 | 0.05 | -0.06 | |
| Cash per share | 0.04 | 0.02 | 0.04 | 0.02 | 0.03 | |
| Book value per share | 0.11 | 0.09 | 0.1 | 0.08 | 0.04 | |
| Tangible book value per share | 0.11 | 0.09 | 0.1 | 0.08 | 0.04 | |
| Share holders equity per share | 0.11 | 0.09 | 0.1 | 0.08 | 0.04 | |
| Interest debt per share | 0.37 | 0.36 | 0.42 | 0.37 | 0.25 | |
| Market cap | 55.66M | 63.27M | 69.08M | 43.65M | 29.78M | |
| Enterprise value | 71.58M | 79.82M | 87.29M | 60.57M | 49.31M | |
| P/E ratio | -7.01 | -16.06 | 51.86 | -7.6 | -3.51 | |
| Price to sales ratio | 6.74 | 6.69 | 5.82 | 5.48 | 3.72 | |
| POCF ratio | 74.52 | -80.91 | -58.59 | 16.75 | -11.24 | |
| PFCF ratio | -200.23 | -78.79 | -35.08 | 17.02 | -10.45 | |
| P/B Ratio | 9.85 | 13.76 | 13.39 | 11.1 | 15.66 | |
| PTB ratio | 9.85 | 13.76 | 13.39 | 11.1 | 15.66 | |
| EV to sales | 8.67 | 8.44 | 7.35 | 7.61 | 6.16 | |
| Enterprise value over EBITDA | -38.82 | -79.5 | 148.71 | -49.9 | -29.37 | |
| EV to operating cash flow | 95.83 | -102.07 | -74.04 | 23.25 | -18.61 | |
| EV to free cash flow | -257.49 | -99.4 | -44.33 | 23.63 | -17.31 | |
| Earnings yield | -0.04 | -0.02 | 0 | -0.03 | -0.07 | |
| Free cash flow yield | 0 | -0.01 | -0.03 | 0.06 | -0.1 | |
| Debt to equity | 3.2 | 3.84 | 3.96 | 4.61 | 6.37 | |
| Debt to assets | 0.54 | 0.56 | 0.6 | 0.56 | 0.37 | |
| Net debt to EBITDA | -8.63 | -16.48 | 31.03 | -13.94 | -11.64 | |
| Current ratio | 0.99 | 0.86 | 0.9 | 0.88 | 1.05 | |
| Interest coverage | -12.35 | -6.48 | 2.35 | -5.71 | -8.43 | |
| Income quality | -0.38 | 0.67 | -3.53 | -1.81 | 1.25 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.25 | 0 | 0.18 | 0.21 | 0 | |
| Research and developement to revenue | 0.09 | 0.11 | 0.08 | 0.13 | 0.1 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.37 | 0.03 | 0.67 | -0.02 | 0.08 | |
| Capex to revenue | -0.12 | 0 | -0.07 | -0.01 | -0.02 | |
| Capex to depreciation | 1.29 | -0.12 | -4.59 | -0.23 | -0.91 | |
| Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Graham number | 0.32 | 0.2 | 0.13 | 0.23 | 0.19 | |
| ROIC | -0.05 | -0.03 | 0.02 | -0.04 | -0.08 | |
| Return on tangible assets | -0.06 | -0.03 | 0.01 | -0.04 | -0.06 | |
| Graham Net | -0.36 | -0.37 | -0.37 | -0.4 | -0.44 | |
| Working capital | -210K | -2.34M | -2.01M | -2.11M | 713K | |
| Tangible asset value | 5.65M | 4.6M | 5.16M | 3.93M | 1.9M | |
| Net current asset value | -11.28M | -12.36M | -11.77M | -12.87M | -14.68M | |
| Invested capital | 3.2 | 3.84 | 3.96 | 4.61 | 6.37 | |
| Average receivables | 5.05M | 4.56M | 5.05M | 4.46M | 3.33M | |
| Average payables | 5.88M | 6.2M | 5.49M | 5.61M | 6.33M | |
| Average inventory | 9.22M | 8.48M | 8.27M | 9.27M | 10.08M | |
| Days sales outstanding | 51.57 | 41.68 | 43.35 | 36.18 | 38.95 | |
| Days payables outstanding | 78.47 | 74.29 | 54.43 | 87.79 | 76.12 | |
| Days of inventory on hand | 109 | 99.98 | 92.36 | 141.73 | 119.53 | |
| Receivables turnover | 1.75 | 2.16 | 2.08 | 2.49 | 2.31 | |
| Payables turnover | 1.15 | 1.21 | 1.65 | 1.03 | 1.18 | |
| Inventory turnover | 0.83 | 0.9 | 0.97 | 0.63 | 0.75 | |
| ROE | -0.35 | -0.21 | 0.06 | -0.37 | -1.12 | |
| Capex per share | -0.02 | 0 | -0.02 | 0 | 0 |
NANX Frequently Asked Questions
What is Nanophase Technologies Corporation stock symbol ?
Nanophase Technologies Corporation is a US stock , located in Romeoville of Il and trading under the symbol NANX
What is Nanophase Technologies Corporation stock quote today ?
Nanophase Technologies Corporation stock price is $0.976 today.
Is Nanophase Technologies Corporation stock public?
Yes, Nanophase Technologies Corporation is a publicly traded company.
Company Profile
- Volume Average 9.92K
- Market Capitalization 51.24M
- Employee 79
- CEO Mr. Jess A. Jankowski
- Headquarters Romeoville,IL,US
- IPO Date 1997-11-26
-
Website
https://www.nanophase.com 
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
